WHO Halts Hydroxychloroquine Testing Over Safety Concerns
WHO Halts Hydroxychloroquine Testing Over Safety Concerns
A paper published in The Lancet reported that hospitalized COVID-19 patients taking the drug had a higher risk of death, although some researchers have raised questions about the data.
WHO Halts Hydroxychloroquine Testing Over Safety Concerns
WHO Halts Hydroxychloroquine Testing Over Safety Concerns

A paper published in The Lancet reported that hospitalized COVID-19 patients taking the drug had a higher risk of death, although some researchers have raised questions about the data.

A paper published in The Lancet reported that hospitalized COVID-19 patients taking the drug had a higher risk of death, although some researchers have raised questions about the data.

liver, evolution, disease & medicine
Alzheimer’s Gene Linked to Higher Risk of Severe COVID-19
Alzheimer’s Gene Linked to Higher Risk of Severe COVID-19
Jef Akst | May 26, 2020
Two copies of the APOE4 variant, which confers a higher risk of dementia, doubles the risk of severe symptoms as a result of infection with SARS-CoV-2, according to a study.
SARS-CoV-2 Protein Hampers Innate Immune Reaction In Vitro
SARS-CoV-2 Protein Hampers Innate Immune Reaction In Vitro
Abby Olena | May 21, 2020
The viral protein known as ORF3b limits the induction of the type I interferon response, which typically alerts other immune system components to the presence of a virus, in cultured cells.
Humans Inoculated with Genetically Modified Malaria Parasites
Humans Inoculated with Genetically Modified Malaria Parasites
Ruth Williams | May 20, 2020
Engineered Plasmodium parasites form the basis of two experimental malaria vaccines that showed safety and encouraging immune responses in clinical trials.
Losing Touch: Another Drawback of the COVID-19 Pandemic
Losing Touch: Another Drawback of the COVID-19 Pandemic
Ashley Yeager | May 19, 2020
Affectionate touches tap into the nervous system’s rest and digest mode, reducing the release of stress hormones, bolstering the immune system, and stimulating brainwaves linked with relaxation.
Moderna’s Coronavirus Vaccine Spurs Immune Response: Early Data
Moderna’s Coronavirus Vaccine Spurs Immune Response: Early Data
Ashley Yeager | May 18, 2020
A clinical trial of the shot in eight volunteers suggests that it is safe and that it generates antibodies that neutralize SARS-CoV-2, but further testing is needed, scientists say.
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
Shawna Williams | May 15, 2020
While the finding doesn’t prove people become immune to the virus after infection, it is good news for vaccine development.
Droplets from Speech Can Float in Air for Eight Minutes: Study
Droplets from Speech Can Float in Air for Eight Minutes: Study
Kerry Grens | May 15, 2020
The experiments did not involve SARS-CoV-2, but researchers say the results support precautions to avoid possibly spreading COVID-19 by talking.
Cal State University to Conduct Most Classes Online this Fall
Cal State University to Conduct Most Classes Online this Fall
Catherine Offord | May 13, 2020
The public university system in California joins a number of colleges planning a virtual semester to minimize the risk of spreading COVID-19.
Loss of Smell, Taste May Be Reliable Predictor of COVID-19: Study
Loss of Smell, Taste May Be Reliable Predictor of COVID-19: Study
Ashley Yeager | May 12, 2020
Data from a crowdsourcing smartphone app is helping to track the spread of the disease in real time and reveals the symptom as the number one indicator of infection.